Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Tideglusib

EU orphan designation number: EU/3/15/1452   
Active ingredient: Tideglusib
Indication: Treatment of fragile X syndrome
Sponsor: AMO Pharma Ltd
Throwsters The Street, Wonersh, Surrey GU5 0PF, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/03/2015 Orphan designation EMA/OD/253/14 (2015)2018 of 19/03/2015
03/05/2016 Transfer of orphan designation EMA/OD/253/14/T/01 (2016) 2747 of 28/04/2016